These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
526 related articles for article (PubMed ID: 25940718)
1. Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis. Gallego CJ; Shirts BH; Bennette CS; Guzauskas G; Amendola LM; Horike-Pyne M; Hisama FM; Pritchard CC; Grady WM; Burke W; Jarvik GP; Veenstra DL J Clin Oncol; 2015 Jun; 33(18):2084-91. PubMed ID: 25940718 [TBL] [Abstract][Full Text] [Related]
2. Next Generation Sequencing in the Clinic: a Patterns of Care Study in a Retrospective Cohort of Subjects Referred to a Genetic Medicine Clinic for Suspected Lynch Syndrome. Gallego CJ; Perez ML; Burt A; Amendola LM; Shirts BH; Pritchard CC; Hisama FM; Bennett RL; Veenstra DL; Jarvik GP J Genet Couns; 2016 Jun; 25(3):515-9. PubMed ID: 26637299 [TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes. Gallego CJ; Bennette CS; Heagerty P; Comstock B; Horike-Pyne M; Hisama F; Amendola LM; Bennett RL; Dorschner MO; Tarczy-Hornoch P; Grady WM; Fullerton SM; Trinidad SB; Regier DA; Nickerson DA; Burke W; Patrick DL; Jarvik GP; Veenstra DL Contemp Clin Trials; 2014 Sep; 39(1):1-8. PubMed ID: 24997220 [TBL] [Abstract][Full Text] [Related]
4. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ladabaum U; Wang G; Terdiman J; Blanco A; Kuppermann M; Boland CR; Ford J; Elkin E; Phillips KA Ann Intern Med; 2011 Jul; 155(2):69-79. PubMed ID: 21768580 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of genetic diagnostic strategies for Lynch syndrome in Italy. Pastorino R; Basile M; Tognetto A; Di Marco M; Grossi A; Lucci-Cordisco E; Scaldaferri F; De Censi A; Federici A; Villari P; Genuardi M; Ricciardi W; Boccia S PLoS One; 2020; 15(7):e0235038. PubMed ID: 32609729 [TBL] [Abstract][Full Text] [Related]
6. A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients. Snowsill T; Huxley N; Hoyle M; Jones-Hughes T; Coelho H; Cooper C; Frayling I; Hyde C BMC Cancer; 2015 Apr; 15():313. PubMed ID: 25910169 [TBL] [Abstract][Full Text] [Related]
7. Expanding the genotype-phenotype spectrum in hereditary colorectal cancer by gene panel testing. Rohlin A; Rambech E; Kvist A; Törngren T; Eiengård F; Lundstam U; Zagoras T; Gebre-Medhin S; Borg Å; Björk J; Nilbert M; Nordling M Fam Cancer; 2017 Apr; 16(2):195-203. PubMed ID: 27696107 [TBL] [Abstract][Full Text] [Related]
8. Cost Effectiveness of Sequencing 34 Cancer-Associated Genes as an Aid for Treatment Selection in Patients with Metastatic Melanoma. Li Y; Bare LA; Bender RA; Sninsky JJ; Wilson LS; Devlin JJ; Waldman FM Mol Diagn Ther; 2015 Jun; 19(3):169-77. PubMed ID: 25926090 [TBL] [Abstract][Full Text] [Related]
9. Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial. Mittmann N; Au HJ; Tu D; O'Callaghan CJ; Isogai PK; Karapetis CS; Zalcberg JR; Evans WK; Moore MJ; Siddiqui J; Findlay B; Colwell B; Simes J; Gibbs P; Links M; Tebbutt NC; Jonker DJ; ; J Natl Cancer Inst; 2009 Sep; 101(17):1182-92. PubMed ID: 19666851 [TBL] [Abstract][Full Text] [Related]
10. Colorectal adenomatous polyposis syndromes: Genetic determinism, clinical presentation and recommendations for care. Buecher B Bull Cancer; 2016 Feb; 103(2):199-209. PubMed ID: 26805944 [TBL] [Abstract][Full Text] [Related]
11. Genetic predisposition to colorectal cancer: Implications for treatment and prevention. Stoffel EM; Yurgelun MB Semin Oncol; 2016 Oct; 43(5):536-542. PubMed ID: 27899184 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting. Snowsill TM; Ryan NAJ; Crosbie EJ; Frayling IM; Evans DG; Hyde CJ PLoS One; 2019; 14(8):e0221419. PubMed ID: 31469860 [TBL] [Abstract][Full Text] [Related]
13. Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients. Tanskanen T; Gylfe AE; Katainen R; Taipale M; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P; Aaltonen LA Scand J Gastroenterol; 2013 Jun; 48(6):672-8. PubMed ID: 23544471 [TBL] [Abstract][Full Text] [Related]
14. Can we identify the high-risk patients to be screened? A genetic approach. Gammon A; Kohlmann W; Burt R Digestion; 2007; 76(1):7-19. PubMed ID: 17947814 [TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of a new strategy to identify HNPCC patients. Kievit W; de Bruin JH; Adang EM; Severens JL; Kleibeuker JH; Sijmons RH; Ruers TJ; Nagengast FM; Vasen HF; van Krieken JH; Ligtenberg MJ; Hoogerbrugge N Gut; 2005 Jan; 54(1):97-102. PubMed ID: 15591512 [TBL] [Abstract][Full Text] [Related]
16. Who should be sent for genetic testing in hereditary colorectal cancer syndromes? Lynch HT; Boland CR; Rodriguez-Bigas MA; Amos C; Lynch JF; Lynch PM J Clin Oncol; 2007 Aug; 25(23):3534-42. PubMed ID: 17687158 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of population-wide genomic screening for Lynch syndrome in the United States. Guzauskas GF; Jiang S; Garbett S; Zhou Z; Spencer SJ; Snyder SR; Graves JA; Williams MS; Hao J; Peterson JF; Veenstra DL Genet Med; 2022 May; 24(5):1017-1026. PubMed ID: 35227606 [TBL] [Abstract][Full Text] [Related]
20. [Current concepts in the genetics of hereditary and sporadic colorectal cancer and the role of genetics in patient management. Hereditary colorectal cancers]. Lakatos PL; Lakatos L Orv Hetil; 2006 Feb; 147(8):363-8. PubMed ID: 16579336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]